The platform built by the startup can complete tasks like resume-screening, financial document analysis and stock analysis ...
The use of bispecific antibodies (BsAb) before chimeric antigen receptor T-cell therapy (CAR-T) appeared to be a more optimal ...
Morning Overview on MSNOpinion
AI backlash surged in 2025, here’s what drove it
Across politics, workplaces and everyday apps, 2025 turned into a breaking point for public patience with artificial ...
Cold plunge therapy sits in an interesting place in the recovery landscape. The evidence for short-term recovery benefits and ...
“Our findings indicate that the vaccine provided a significant enhanced level of protection against these infections in the target population," the authors concluded. "Furthermore, these results ...
The deal arrives as Meta accelerates its AI investments to compete with Google, Microsoft, and OpenAI — and as the industry’s ...
On the Morning Brief, Yahoo Finance executive editor Brian Sozzii is examining the biggest developing market stories on ...
Meta’s stock has shown strong performance with a market capitalization of $1.68 trillion as of the market open. Over the past ...
Shares of Meta Platforms, Inc. (NASDAQ: META) are rising Tuesday. The company announced the acquisition of an agentic AI ...
Meta has acquired an AI startup called Manus known for its custom research and website-building agents in a deal valued at more than $2 billion.
Facebook owner Meta has agreed to acquire Manus, an artificial intelligence agent created by a company founded in China but ...
Menopause hormone therapy neither increases nor decreases the risk for dementia or mild cognitive impairment in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results